PRA International
A leading global CRO, PRA is transforming clinical trials through our people, innovation and transparency. We serve clients across all phases of pharmaceutical and biotech drug development by combining therapeutic and operational expertise with local knowledge. Offering services in 80+ countries and serving sponsors for 30+ years.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.
Uniphar
Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.
Company Details
Latest Content from PMHub
Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions
Videos and Podcasts | January 18, 2024 | Impetus Digital
In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today's diverse healthcare landscape. 7....
Genesis Research Group RWD / HTA / regulatory / ECA webinar on 15 Feb: reserve your place!
Press Releases | January 17, 2024 | Genesis Research Group
On 15 February 2024, Carole Longson and Allie Sosinsky of Genesis Research Group, a leading global provider of tech-enabled real-world evidence, market access, and HEOR solutions, will present a webinar...
Clinical trials explained: Why iconography matters…
Press Releases | January 17, 2024 | Cuttsy + Cuttsy
Icons serve as a useful form of alternative communication. We spend a lot of time developing icons for healthcare communications. Find out how we use iconography to elevate clinical trial...
Bringing omnichannel to medical affairs: what do you need to know?
White Papers and Resources | January 16, 2024 | Amiculum
By Frank Fisher
Trends in Virtual Collaboration
White Papers and Resources | January 15, 2024 | Impetus Digital
Join us for a look at the top-5 emerging virtual collaboration trends...
Unlock possibilities: A Medical Affairs strategy fit for the future
White Papers and Resources | January 15, 2024 | OPEN Health
Explore the key areas to include in a Medical Affairs strategy and plan that is fit for the future in our latest whitepaper.
Why Words Matter: Person-first language in the age of identity
White Papers and Resources | January 12, 2024 | Mednet
We take a look at why the words we use in medcomms matter and examine the use of patient-first language
Advancing digital engagement in pharma and healthcare: 2024 focus areas
Press Releases | January 12, 2024 | Graphite Digital
6 areas for pharma and healthcare organisations to focus efforts in 2024 to drive better digital engagement amongst patients, HCPs and other users
Advisor Questions on Potential Data or Knowledge Gaps
Videos and Podcasts | January 11, 2024 | Impetus Digital
As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...
On a journey to diverse, inclusive, and more efficient rare disease trials
White Papers and Resources | January 5, 2024 | Impetus Digital
Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care...